The endocrine pancreas during exercise in people with and without type 1 diabetes: Beyond the beta-cell
- PMID: 36147573
- PMCID: PMC9485437
- DOI: 10.3389/fendo.2022.981723
The endocrine pancreas during exercise in people with and without type 1 diabetes: Beyond the beta-cell
Abstract
Although important for digestion and metabolism in repose, the healthy endocrine pancreas also plays a key role in facilitating energy transduction around physical exercise. During exercise, decrements in pancreatic β-cell mediated insulin release opposed by increments in α-cell glucagon secretion stand chief among the hierarchy of glucose-counterregulatory responses to decreasing plasma glucose levels. As a control hub for several major glucose regulatory hormones, the endogenous pancreas is therefore essential in ensuring glucose homeostasis. Type 1 diabetes (T1D) is pathophysiological condition characterised by a destruction of pancreatic β-cells resulting in pronounced aberrations in glucose control. Yet beyond the beta-cell perhaps less considered is the impact of T1D on all other pancreatic endocrine cell responses during exercise and whether they differ to those observed in healthy man. For physicians, understanding how the endocrine pancreas responds to exercise in people with and without T1D may serve as a useful model from which to identify whether there are clinically relevant adaptations that need consideration for glycaemic management. From a physiological perspective, delineating differences or indeed similarities in such responses may help inform appropriate exercise test interpretation and subsequent program prescription. With more complex advances in automated insulin delivery (AID) systems and emerging data on exercise algorithms, a timely update is warranted in our understanding of the endogenous endocrine pancreatic responses to physical exercise in people with and without T1D. By placing our focus here, we may be able to offer a nexus of better understanding between the clinical and engineering importance of AIDs requirements during physical exercise.
Keywords: endocrine pancreas; exercise; pancreatic hormones; physical activity; type 1 diabetes.
Copyright © 2022 McCarthy, Schmidt, Christensen, Bain, Nørgaard and Bracken.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures

Similar articles
-
Pancreatic Alpha-Cells Contribute Together With Beta-Cells to CXCL10 Expression in Type 1 Diabetes.Front Endocrinol (Lausanne). 2020 Sep 15;11:630. doi: 10.3389/fendo.2020.00630. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 33042009 Free PMC article.
-
Role of the clock gene Rev-erbα in metabolism and in the endocrine pancreas.Diabetes Obes Metab. 2015 Sep;17 Suppl 1:106-14. doi: 10.1111/dom.12522. Diabetes Obes Metab. 2015. PMID: 26332975 Review.
-
Increased Expression of Viral Sensor MDA5 in Pancreatic Islets and in Hormone-Negative Endocrine Cells in Recent Onset Type 1 Diabetic Donors.Front Immunol. 2022 Mar 11;13:833141. doi: 10.3389/fimmu.2022.833141. eCollection 2022. Front Immunol. 2022. PMID: 35359976 Free PMC article.
-
[Pax4 transdifferentiates glucagon-secreting alpha cells to insulin-secreting beta endocrine pancreatic cells].Med Sci (Paris). 2009 Aug-Sep;25(8-9):763-5. doi: 10.1051/medsci/2009258-9763. Med Sci (Paris). 2009. PMID: 19765395 French. No abstract available.
-
Decoding the Significance of Alpha Cell Function in the Pathophysiology of Type 1 Diabetes.Cells. 2024 Nov 19;13(22):1914. doi: 10.3390/cells13221914. Cells. 2024. PMID: 39594662 Free PMC article. Review.
Cited by
-
Insulin therapy in type 2 diabetes: Insights into clinical efficacy, patient-reported outcomes, and adherence challenges.World J Diabetes. 2024 May 15;15(5):828-852. doi: 10.4239/wjd.v15.i5.828. World J Diabetes. 2024. PMID: 38766443 Free PMC article. Review.
-
Pharmacologic inhibition of somatostatin receptor 2 to restore glucagon counterregulation in diabetes.Front Pharmacol. 2024 Jan 17;14:1295639. doi: 10.3389/fphar.2023.1295639. eCollection 2023. Front Pharmacol. 2024. PMID: 38298268 Free PMC article. Review.
-
Editorial: Integrative exercise endocrinology.Front Endocrinol (Lausanne). 2024 Jan 9;14:1350462. doi: 10.3389/fendo.2023.1350462. eCollection 2023. Front Endocrinol (Lausanne). 2024. PMID: 38264284 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials